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Abstract 
 
Carbapenems are one of the most widely used groups of antibiotics because 
of their broad spectrum against both gram positive and gram negative 
bacteria. The biosynthesis of the simplest carbapenem, 1-carbapen-2-em-3-
carboxylic acid (Car) is controlled by an operon of eight genes, CarA-H. 
CarG is believed to possess a function of self-resistance but the mechanism 
is not solved. The structure of CarG was solved a few years ago. The aim of 
this study was to improve the crystal quality to open up for further binding 
studies on CarG. 
   The protein was purified in a 4 step process; Ni2+-column, desalting, 
MonoQ and gelfiltration. MonoQ was added to the previous protocol with 
hope to further purify the protein. Different screening protocols were used 
and as in earlier studies of CarG, AmSO4 was a suitable precipitant. Crystals 
were obtained in a concentration range between 1.3-1.8 M AmSO4 and pH 
7.5 and 8, respectively. Using these conditions seeding techniques and 
cocrystallization with imipenem and meropenem were performed.  
    In this study I show that by adding MonoQ chromatography to the 
purification protocol bigger crystals and more single crystals can be 
obtained. Seeding, in drops with no substrate added, resulted in more 
square-shaped crystals but often much thinner crystals. Results from 
cocrystallization and seeding with imipenem show no improvement in 
crystal quality. Cocrystallization with meropenem gave clear crystals but 
was not further improved by seeding. 
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1 Introduction 
 
Antibiotic resistance is a huge topic in today’s medical area. One of the 
biggest issues is the prescribing of antibiotic before a full diagnose and 
analysis of the cause of the symptoms has been performed. Antibiotics are 
sometimes given to patients with no bacterial infection or the wrong 
antibiotic is prescribed. This will lead to bacteria getting resistant to many 
antibiotics and these bacteria are easily spread causing minor infections to 
be life threatening. Carbapenems belong to a class of β-lactam antibiotics 
that are clinically used widely because of their broad spectrum activity 
against both gram positive and gram negative bacteria (Kropp et al., 1980) 
and also because of their resistance to β-lactamases.  The first carbapenem 
to be isolated from Streptomyces cattleya was Thienamycin (Kahan et al., 
1979) but as it turned out it was too unstable to be suitable for clinical use. 
Instead Imipenem, a derivative to Thienamycin, was chemically produced to 
be more stable and is today clinically used successfully (Kahan, 1983).  
    1-carbapen-2-em-3-carboxylic acid (Car) is the most simple carbapenem 
(figure 1a) and was first found and isolated from Erwinia carotovora and 
Serratia marcescens in 1982 (Parker et al., 1982). The biosynthesis is 
regulated by an operon of eight genes; CarA-H, which in turn are regulated 
by CarR (McGowan et al., 1995). These genes were sequenced and 
analyzed by McGowan and coworkers (1996) and revealed that CarA and 
CarC have homologues in the cluster of genes that are responsible for the 
expression of clavulanic acid in Streptomyces clavuligerus. Clavulanic acid 
has also a β-lactam core ring structure (figure 1b) and acts as an inhibitor of 
β-lactamases. CarR is a LuxR-type transcriptional activator that by concert 
with N-acyl homoserine lactones (N-AHL) induces the transcription of the 
carbapenem biosynthetic gene cluster (McGowan et al., 1995; Thomson et 
al., 2000). These N-AHL can act as signaling molecules and through cell 
density signal to neighboring cells and coordinate their gene expression. 
This is called quorum sensing control (Bainton et al., 1992; Thomson et al., 
2000; Welch et al., 2000). 
   The structures of CarA and CarC have been solved to 2.3 and 2.4Å, 
respectively (Clifton et al., 2003; Miller et al., 2003). Both are required for 
the biosynthesis together with CarB (McGowan et al., 1997; Sleeman et al., 
2005). CarD and CarE also have a function in the biosynthesis while CarF 
and CarG together seem to have a self-resistant function (McGowan et al., 
1997). CarF and CarG knockouts show sensitiveness to carbapenem. The 
function of CarH is still unknown.  
   The structure of CarG has previously been solved to 2.3Å (K. Valegård, 
personal communication) but no binding studies, to investigate the self-
resistance function of CarG have been done so far. Troubles with 
intergrown crystals in this study would be problematic in further binding 
studies. The three-dimensional structure contains two anti-parallel β-sheets 
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with a total of twelve β-strands and with one α-helix in the C-terminus 
(figure 2).  
 
        
 
Figure 1. Molecule structure of (A) Car and (B) Clavulanic acid  
 
 
 
Figure 2. Three-dimensional structure of CarG solved to 2.3 Å.  
 
Since carbapenems are important for clinical use it is of great importance 
that the production of the antibiotic is both cost and time effective. With 
more knowledge about the synthesis and function of the proteins encoded by 
the carbapenem cluster the production process can be developed to be more 
effective. It could perhaps also lead to the development of even more 
effective new antibiotics.  
   This study will focus on CarG and of improving the crystal quality. This 
will be done by refining the purification protocol and by adding possible 
substrates to the protein that could stabilize the protein. In this case crystal 
quality will be judged by eye.  
 
2 Materials and Methods 
 
2.1   Cultivation 
CarG from Erwinia carotovora was cloned to the pET-30a-c(+) vector by 
Dr. Tom Taylor. The plasmid was transformed into E. coli BL21(DE3) 
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cells. Glycerol stock solutions with transformed E. coli BL21(DE3) cells 
were spread on LB plates with Kanamycin to grow. Several colonies were 
inoculated in an overnight culture (25ml 2TY media and 0.1 mM 
Kanamycin) at 37ºC with a shake of 170 rpm. Fifteen ml of the overnight 
culture were transferred to 500 ml 2TY media with 0.1 mM Kanamycin and 
placed on a shaker at 37ºC. When the culture had an OD600 between 0.6-0.8 
the temperature was reduced to 18ºC. After 30 min IPTG (0.1 mM) was 
added to the culture to induce expression of CarG. The incubation continued 
for 16h at 18ºC. 
The cells were harvested by centrifugation on a Sorvall SLA-1500 rotor for 
15 min, 4ºC, 10000 rpm. The cells were divided in two parts. The first part, 
6g cells, was used immediately and resuspended in 50 ml 0.02 M sodium 
phosphate pH 7.4, 0.5 M NaCl , one complete EDTA-free protease inhibitor 
cocktail tablet (Roche Diagnostics GmbH, Mannheim, Germany), 2 mM 
MgCl2 and 10 µl Benzonase Nuclease (Novagen, Denmark). Cell lysis  was 
performed using a cell disrupter (Constant Cell Disruptor Systems, 
Daventry, UK)  and diluting to approximately 70 ml with 0.02 M sodium 
phosphate pH 7.4, 0.5 M NaCl. The cell lysate was cleared by centrifugation 
in a Sorvall  SS-34 rotor (30 min, 4ºC , 20000 rpm).  
The cells that were not used immediately were centrifuged on Biofuge 
Primo at 6000xg in 30 min and the pellet was then frozen at -20ºC. When 
thawed, it was treated the same way as the fresh cells.  
 
2.2   Purification 
A 5 ml HiTrap Chelating HP column (GE Healthcare Bio Sciences AB, 
Uppsala, Sweden) loaded with Ni2+ was used for the first purification step. 
The cell lysate was applied and the column was washed with 0.02 M sodium 
phosphate pH 7.4, 0.5 M NaCl. A gradient of 0.0-0.5 M imidazole was used 
to elute the poly-His-tagged CarG protein. 2 ml fractions were collected and 
A260/A280 was measured for the peak fractions. Fractions with values below 
one were pooled together. The sample was run through a 53 ml High prep 
26/10 desalting column (GE Healthcare Bio Sciences AB, Uppsala, 
Sweden) with 0.1 M HEPES pH 7.5 buffer. The desalting column clears the 
sample from imidazole and salt. As an extra step, in the hope to improve the 
purification, MonoQ chromatography was performed. The protein fractions 
from the desalting process were pooled and loaded onto the MonoQ 10/100 
GL column (GE Healthcare Bio Sciences AB, Uppsala, Sweden) and the 
column was washed with 0.1 M HEPES pH 7.5. The protein was eluted with 
a gradient of NaCl from 0.0-0.5 M. Fractions, corresponding to the eluted 
protein, were run on a SDS gradient gel (8-25%). The gel was stained with 
either Coomassie blue or AcquaStain.  Fractions with satisfactory purity 
were then pooled together. The protein sample was applied to a HiLoad 
26/60 Superdex 200 prep grade column (GE Healthcare Bio Sciences AB, 
Uppsala, Sweden) and washed through with 0.1 M HEPES pH 7.5. The 
purified protein was concentrated to approximately 10 mg/ml in a 
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Vivaspin20 (Sartorius Stedim Biotech, Germany) and stored at -20ºC for 
crystallization. The purification process was performed three times and each 
time the pooling of fractions was done a bit stricter. In the last purification 
the peak fractions from MonoQ chromatography were divided in two 
samples, 1 and 2. Both samples were preceded to the gel filtration 
separately. They were later compared in a crystallization experiment.  
 
2.3   Crystallization 
At first, different screening protocols were used such as JCSG , pH clear 
and AmSO4 Suite from Qiagen, Crystal screen from Hampton and Proplex 
from Molecular dimensions. They were all performed with sitting drop 
vapor diffusion: 1µl protein (10 mg/ml) and 1µl reservoir solution were 
mixed. 
   From a previous experiment a set up of different pH and concentration of 
AmSO4 were elaborated to grow crystals (K. Valegård, personal 
communication), see figure 3. These crystals were used for seeding. Two µl 
protein (10 mg/ml) were mixed with 2 µl reservoir solution using the 
hanging drop vapor diffusion technique. 
   When comparing the two separated samples from the last purification, the 
crystallization conditions in figure 3 were used.  
 
 
Figure 3. A scheme of conditions elaborated from earlier studies on CarG. These 
conditions were used as a first step in optimizing the crystallization and the crystals were 
also used for seeding.  
 
 
2.3.1   Cocrystallization with imipenem and meropenem 
Cocrystallization with 0.5 mM imipenem (Sigma-Aldrich, USA) and 0.5 
mM meropenem (Sigma-Aldrich, USA) was carried out by hanging drop 
vapor diffusion with the same conditions as in figure 3 and using a protein 
concentration of 10 mg/ml.  
 
2.3.2   Seeding 
Seeding was performed in drops with no substrate added but also on 
cocrystallization drops with imipenem and meropenem. Crystals were 
collected, crushed and resuspended in 100 µl of the reservoir solution. This 
seeding solution was then diluted (10 & 100 times) and spread with a cat 
whisker on one day old hanging drops.  
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2.3.3   Additives 
In one part of the experiment additives were added to the crystallization 
conditions hoping to get higher quality crystals. Additive Screen 
Formulation (Hampton Research) was used with sitting drop vapor diffusion 
with the reservoir solution 1.6 M AmSO4, 0.1 M HEPES pH 8. 
 
3 Results 
 
3.1   Cultivation and Purification 
E. coli BL21(DE3) expressing His-tagged CarG was cultivated in 2TY 
media and kanamycin. It was then purified in a four step process with a 
Ni2+-column, desalting, MonoQ and gelfiltration.  
   After the first purification step (Ni2+-column) the protein samples were 
run on a SDS-gradient gel to verify the purity. The wells clogged of all the 
protein and the migratory protein was just a smear, figure 4. Because of this 
it was difficult to judge the purity of the samples but since A260/A280 was 
measured the fractions with most protein and less nucleotides could be 
pooled together. The ratio between A260 and A280 is a measurement of how 
much protein and DNA/RNA there is in a sample. The curve from MonoQ 
purification showed a split peak (figure 5). The split peak indicates that 
there is different folding of CarG with a slightly difference in charge and 
size. The peak-fractions were run on a SDS-gradient gel to verify the purity. 
Figure 6 shows one of these SDS-gradient gels where a thick band 
corresponding to the CarG proteins was seen at just below 30 kDa. Lane 3 
and 4 seem to have one band while in Lane 5 a thinner band starts to be 
visible. Protein corresponding to Lane 3 and 4 were pooled (sample 1) while 
sample corresponding to Lane 5 was held alone (sample 2). By strictly 
pooling the highest peak the more rare folded proteins gets excluded. 
Nucleotide that is eluted later is also excluded.  
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Figure 4. SDS-gradient gel analysis (8-25% acrylamide) after HiTrap Chelating HP 
chromatography. Stained with Coommassie Blue. Lane 1-7: Protein from peak-fractions. 
Lane 8: Low molecular weight marker. Size  from the top: 97.0, 66.0, 45.0, 30.0, 20.1, and 
14.4 kDa. 
 
 
  
Figure 5. Elution curve from MonoQ chromatography 
 
 
Figure 6. SDS-gradient gel analysis (8-25% acryl amid) after MonoQ chromatography. 
Stained with AcquaStain. Lane 1-7: Continues samples from the elution. Lane 3 and 4 are 
the absolute peak fractions and 5 is the slope of the peak. Lane 8 is a low molecular weight 
marker (from the top 97.0, 66.0, 45.0, 30.0, 20.1, and 14.4 kDa). The arrow indicates the 
size of the marker-band closest to the expressed protein.
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3.2   Crystallization 
A lot of different methods were tried to optimize and get better quality 
crystals. None of the big screening suites (JCSG, pH clear, AmSO4 Suite, 
Crystal screen and Proplex) gave any results that could be further used 
except AmSO4 that was known from before to work for obtaining CarG 
crystals. The comparison of sample 1 and 2 from the last MonoQ 
purification did not show much difference in crystal appearance (figure 7A-
B) but they both showed better crystals then from earlier purification 
processes (figure 7A-C). More single crystals were observed and they were 
also more square-shaped and bigger. 
  
 
Figure 7. Crystals obtained in AmSO4.  (A,B) These crystals are obtained from protein in 
the same purification process. (A) Protein from the top peak fractions with only one band 
visible in the SDS-gradient gel (sample 1). Reservoir solution: 1.6 M AmSO4, 0.1 M 
HEPES pH 7.5. (B) Protein from peak fractions but where two bands were visible in the 
SDS-gradient gel (sample 2). Reservoir solution: 1.6 M AmSO4, 0.1 M HEPES pH 8. (C) 
Crystals obtained from a second purification process where the pooling of peak fractions 
was made less strict. Reservoir solution: 1.6 M AmSO4, 0.1 M HEPES pH 7. 
 
3.2.1   Cocrystallization and Seeding 
Crystallization protocol in figure 3 was used to grow crystals for seeding 
and it was also used as a control to see whether the seeding worked or not. It 
was clear that the protein needs higher AmSO4 concentrations to form 
crystals without seeding since no crystals grew in AmSO4 concentration 
between 1.3-1.5 M. After performing seeding, crystals grew even in the 
lower concentrations. When comparing non-seeded crystals with seeded 
crystals the seeded crystals are often more square-like without that lobed 
appearance but they are also much thinner, see figure 8A-C. Figure 8D is an 
enlargement of a crystal from the most diluted seeding solution.   
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Figure 8. Seeded crystals obtained in 1.6 M AmSO4, 0.1 M HEPES pH8. (A) Seeded with 
stock solution. (B) Seeded with a 10-1 dilution. (C) Seeded with a 10-2 dilution (D) An 
enlargement of a crystal from figure 8C. 
 
   Crystals co-crystallized with imipenem shows a mix of square-shaped 
single crystals and intergrown crystals (figure 9A). Using the seeding 
technique the crystals got smaller and less single crystals were observed 
(figure 9B). The cocrystallization with meropenem gave clear crystals but 
mostly non-single crystals, seen in figure 9C. After seeding (figure 9D-E) 
more crystals were obtained but mostly thinner and still not many single 
crystals.  
   Figure 9F shows what type of crystal that was used for seeding. This 
crystal was collected from condition: 1.6 M AmSO4, 0.1 M HEPES pH 8.  
 
Common for all crystallization methods the crystals with the highest quality 
were found, with few exceptions, in the conditions with 1.6 M AmSO4 with 
no difference between pH 7.5 and pH 8.0.  
 
3.2.2   Additives 
What was notable was that with cesium chloride and guanidine 
hydrochloride needle-shaped crystals were formed. This has not been 
observed before for CarG. In other aspects it did not show any 
improvement. 
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Figure 9. Seeding and Cocrystallization with imipenem(0.5 mM) and meropenem (0.5 
mM). (A) Cocrystallization with imipenem (1.6 M AmSO4, 0.1M HEPES pH 7.5 (B) Seeding 
and cocrystallization with imipenem (1.6M AmSO4, 0.1M HEPES ) (C) Cocrystallization 
with meropenem (1.6M AmSO4, 0.1M HEPES pH 8) (D,E) Seeding and cocrystallization 
with imipenem (1.3 M AmSO4, HEPES pH 7.5; 1.6 M AmSO4, 0.1 M HEPES pH 8). (F) 
Crystal that was used for seeding (1.6 M AmSO4, 0.1 M HEPES pH 8) 
 
 
4 Discussion 
 
To be able to perform binding studies on protein crystals they need to be of 
high quality. The structure of CarG was solved in 2008 but no binding 
studies have been performed. The purpose of this study was to increase the 
number of high quality crystals to get one step closer to solve the 
mechanism of CarG. Qualities that I looked at were the shape of the crystal, 
the thickness and that it is a single crystal. 
   When the three-dimensional structure of CarG was solved the protein was 
expressed in E-coli BL21(DE3) with pET-30a-c(+) vector (same as in this 
study) and was purified with Ni2+-column, desalting-column and 
gelfiltration. The crystal were grown in 1.6 M AmSO4, 0.1 M HEPES pH 8 
using the hanging-drop vapor diffusion technique (K. Valegård, personal 
communication) 
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   By adding MonoQ chromatography to the purification protocol I hoped to 
further purify the protein sample. MonoQ is a common method in 
purification of protein and has shown good results in other experiments 
(Joshi & Puri, 2005; Aggarwal et al., 2011) 
I was able to eliminate nucleotides by adding this step but looking at the 
SDS-gradient gel (figure 6) the band of CarG was smeared and it was hard 
to distinguish if there was more than one band. Since some of the peak 
fractions were separated after MonoQ chromatography I was able to see if 
crystals would appear different with the different fractions. But as it turned 
out the crystals appears similar in shape and in the speed of growing. 
However these crystals were of better quality than crystals grown from 
earlier purification where I was less strict when choosing what fractions to 
proceed with. This shows that purification step like MonoQ can improve the 
purity but also that the choosing of fractions are important.  
   The seeding worked in the way that crystals were formed even in the 
conditions where no spontaneous crystallization was observed. With the 
diluted seeding solutions single crystals where observed but they were often 
very thin. The seeding could be further explored by choosing a less 
intergrown crystal to crush. Many times the seeded protein forms crystal 
similar to the seeds. That might be counteracted if the seeds are as small as 
possible. Seeding has for some proteins shown to be a good alternative 
when improving crystal quality (McVey et al., 1997; Van de Water et al., 
2011). The fact that seeding on drops with imipenem caused smaller and 
less single crystals could indicate that CarG crystals grows better without 
too much disturbance. 
   Often you start binding studies by trying substrates found in the 
biosynthesis pathway. An enzyme with the possibility to bind to a substrate 
homologue or an inhibitor could increase its stability. In this case the 
cocrystallization with imipenem and meropenem was an attempt to make 
CarG more stable and more easily form crystals. Meropenem is like 
imipenem a carbapenem but with differences in molecule structure, see 
figure 10. 
 
 
 Figure 10. The molecule structure of (A) imipenem and (B) meropenem. 
 
The cocrystallization with meropenem showed clear crystals but still some 
signs of intergrowing. The clear crystals could still indicate that a binding 
17 
 
has occurred. However, this could only be examined by structure 
determination work.  
   Crystallization is not an easy task and there are several parameters that 
have to be taken in consideration; purification protocol, temperature in 
which the purification is performed, the buffer that is used, storage 
temperature, how the sample is thawed after storage, different precipitants, 
what vector is used and many more. In this case where the protein is cloned 
into a vector with a His-tag one alternative to optimize for crystallization is 
to cleave the His-tag off after purification. Depending of the size of the His-
tag it might disturb the crystallization by flipping back and forth or even 
disturb the active site of a neighboring protein (Tseng et al., 2011; Darmon 
et al., 2012).  Another parameter that could be elaborated is the protein 
concentration. The protein might more easily form crystals in either higher 
or lower protein concentrations.  
   The needle shaped crystals from the additive screening is another part that 
can be further studied. Reservoir conditions can be optimized and single 
needles can be picked for x-ray diffraction.        
   Important to address is that the crystal quality in this case has not been 
examined by x-ray but only visually. Crystals that look fine by eye are not 
always the crystals that give the best diffraction. With a small x-ray beam it 
can be directed to a part of the crystal that is of better quality. Intergrown 
crystals can also be useful if it is possible to divide them in pieces and one 
single piece with high quality can be collected for x-ray analysis. 
 
4.1   Conclusion and further work 
An optimized purification protocol gave crystals with visually higher 
quality. Cocrystallization with meropenem improved the quality by 
generating clear and less intergrown crystals.  In some cases seeding could 
add positive effect to the crystallization. The fact that less intergrown 
crystals were obtained opened up for binding studies. In further studies 
crystals will be soaked with meropenem, imipenem and acyl homoserine 
lactone. Diffraction data will be collected at European Synchrotron 
Radiation Facility (ESRF) in Grenoble, France, in June. 
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